GGrantIndex
← Leaderboards

Francis Ali-Osman

University Of Texas Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$9,395,076
Attributed
$9,395,076
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.6M · FY2005–23
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$30,216,787 · 11

By mechanism

P50$22,158,213 · 3
R01$7,426,956 · 5
P30$375,215 · 2
T32$256,403 · 1

Top collaborators

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Tumor”

Research focus

TumorResponseGliomaMalignant NeoplasmsClinical ResearchDrug ResistancePathway InteractionsBrainBrain NeoplasmsDesignToxic EffectBaseNovel TherapeuticsInnovationEvaluationProgramsScientistClinical TrialsReportingLeadSignal TransductionMalignant Neoplasm Of BrainCollaborationsGlioblastoma

Grant awards (59)

Duke SPORE in Brain Cancer$2,087,855
P50 · FY2023 · CA
Duke SPORE in Brain Cancer$2,086,695
P50 · FY2022 · CA
Duke SPORE in Brain Cancer$1,432,302
P50 · FY2021 · CA
Duke SPORE in Brain Cancer$1,984,462
P50 · FY2020 · CA
Project 3 Supplement - A Novel Cellular Tumor Vaccine Strategy for Mutant IDH1 glioma$160,934
P50 · FY2020 · CA
Duke SPORE in Brain Cancer$2,087,874
P50 · FY2019 · CA
Duke SPORE in Brain Cancer$2,300,000
P50 · FY2018 · CA
Developmental Research Program$106,993
P50 · FY2018 · CA · contact PI
Duke SPORE in Brain Cancer$2,298,025
P50 · FY2017 · CA
Developmental Research Program$99,452
P50 · FY2017 · CA · contact PI
Duke SPORE in Brain Cancer$2,036,564
P50 · FY2016 · CA
Developmental Research Program$84,856
P50 · FY2016 · CA · contact PI
Duke SPORE in Brain Cancer$2,185,000
P50 · FY2015 · CA
Developmental Research Program$91,043
P50 · FY2015 · CA · contact PI
Duke SPORE in Brain Cancer$2,162,000
P50 · FY2014 · CA
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance$306,522
R01 · FY2014 · CA · contact PI
Developmental Research Program$90,104
P50 · FY2014 · CA · contact PI
Experimental Therapeutics$52,657
P30 · FY2014 · CA · contact PI
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance$297,042
R01 · FY2013 · CA · contact PI
Experimental Therapeutics$33,150
P30 · FY2013 · CA · contact PI
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance$316,002
R01 · FY2012 · CA · contact PI
Protein Kinase C and GSTP1 interactions in glioma drug resistance$313,989
R01 · FY2012 · CA · contact PI
Experimental Therapeutics$36,343
P30 · FY2012 · CA · contact PI
Experimental Therapeutics$2,500
P30 · FY2012 · CA · contact PI
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance$316,002
R01 · FY2011 · CA · contact PI
Protein Kinase C and GSTP1 interactions in glioma drug resistance$313,989
R01 · FY2011 · CA · contact PI
Experimental Therapeutics$37,987
P30 · FY2011 · CA · contact PI
Novel Targeted Therapeutics for Cental Nervous System Malignancies$340,769
R01 · FY2010 · CA · contact PI
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance$325,775
R01 · FY2010 · CA · contact PI
Protein Kinase C and GSTP1 interactions in glioma drug resistance$323,700
R01 · FY2010 · CA · contact PI
Experimental Therapeutics$41,676
P30 · FY2010 · CA · contact PI
Novel Targeted Therapeutics for Cental Nervous System Malignancies$335,460
R01 · FY2009 · CA · contact PI
Protein Kinase C and GSTP1 interactions in glioma drug resistance$323,700
R01 · FY2009 · CA · contact PI
EXPERIMENTAL THERAPEUTICS$44,962
P30 · FY2009 · CA · contact PI
Novel Targeted Therapeutics for Cental Nervous System Malignancies$327,069
R01 · FY2008 · CA · contact PI
Protein Kinase C and GSTP1 interactions in glioma drug resistance$316,728
R01 · FY2008 · CA · contact PI
RATIONAL DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS$219,377
P50 · FY2008 · CA · contact PI
EXPERIMENTAL THERAPEUTICS$31,485
P30 · FY2008 · CA · contact PI
Novel Targeted Therapeutics for Cental Nervous System Malignancies$324,799
R01 · FY2007 · CA · contact PI
DNA Methylation and GSTP1 Gene Regulation in Gliomas$322,675
R01 · FY2007 · CA · contact PI
RATIONAL DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS$230,536
P50 · FY2007 · CA · contact PI
EXPERIMENTAL THERAPEUTICS$31,485
P30 · FY2007 · CA · contact PI
Novel Targeted Therapeutics for CNS Malignancies$339,138
R01 · FY2006 · CA · contact PI
DNA Methylation and GSTP1 Gene Regulation in Gliomas$332,312
R01 · FY2006 · CA · contact PI
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS$137,998
P50 · FY2006 · CA · contact PI
EXPERIMENTAL THERAPEUTICS$31,485
P30 · FY2006 · CA · contact PI
DNA Methylation and GSTP1 Gene Regulation in Gliomas$340,310
R01 · FY2005 · CA
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS$138,002
P50 · FY2005 · CA
EXPERIMENTAL THERAPEUTICS$31,485
P30 · FY2005 · CA
DNA Methylation and GSTP1 Gene Regulation in Gliomas$340,310
R01 · FY2004 · CA
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS$138,141
P50 · FY2004 · CA
GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE$247,820
R01 · FY2003 · CA
GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE$242,517
R01 · FY2002 · CA
DNA Methylation and GSTP1 Gene Regulation in Gliomas$190,789
R01 · FY2002 · CA
DNA Methylation and GSTP1 Gene Regulation in Gliomas$127,721
R01 · FY2002 · CA
GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE$237,367
R01 · FY2001 · CA
PEDIATRIC ONCOLOGY RESEARCH TRAINING PROGRAM$139,864
T32 · FY2001 · CA
GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE$224,451
R01 · FY2000 · CA
PEDIATRIC ONCOLOGY RESEARCH TRAINING PROGRAM$116,539
T32 · FY2000 · CA